Dr. Reddy's Schedules Investor Meets in May-June
Dr. Reddy's Laboratories Limited has announced a new series of analyst and institutional investor meetings scheduled from May 20 to June 3, 2026. The meetings will be held in-person across Hong Kong, Singapore, Toronto, Boston, New York, and Princeton, organized by Elara Capital, Bank of America, Nomura, and Investec. The company stated that the schedule is subject to change due to exigencies.
*this image is generated using AI for illustrative purposes only.
Dr. Reddy's Laboratories Limited has announced an updated schedule for its participation in analyst and institutional investor meetings. The company, in an intimation dated May 16, 2026, filed under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, outlined a series of in-person group meets scheduled from May 20, 2026, to June 3, 2026.
Upcoming Investor Meeting Schedule
The management will engage with single institutions and investor groups across various global locations. The meetings are organized by financial institutions including Elara Capital, Bank of America, Nomura, and Investec. The detailed schedule is as follows:
| Date | Organized By | Location | Meeting Mode | Nature of Meet | Timing |
|---|---|---|---|---|---|
| 20.05.2026 | Elara Capital | Hong Kong | In-Person | Group Meet | 09:00 - 18:00 HKT |
| 21.05.2026 – 22.05.2026 | Bank of America | Singapore | In-Person | Group Meet | 08:30 - 18:00 SGT |
| 25.05.2026 | Nomura | Toronto | In-Person | Group Meet | 09:00 - 18:00 ET |
| 28.05.2026 | Nomura | Boston | In-Person | Group Meet | 09:00 - 18:00 ET |
| 29.05.2026 | Nomura | New York | In-Person | Group Meet | 09:00 - 14:00 ET |
| 01.06.2026 – 02.06.2026 | Nomura | New York | In-Person | Group Meet | 09:00 - 18:00 ET |
| 03.06.2026 | Investec | Princeton, New Jersey | In-Person | Group Meet | 10:30 - 11:30 ET |
Regulatory Disclosure
The intimation was submitted to the National Stock Exchange of India Ltd., BSE Limited, New York Stock Exchange Inc., and NSE IFSC Ltd. Dr. Reddy's Laboratories noted that the schedule of these meetings is subject to change due to any exigencies on the part of investors or the company. The filing was signed by K Randhir Singh, Company Secretary, Compliance Officer & Head-CSR.
Historical Stock Returns for Dr Reddys Laboratories
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.33% | -3.90% | -4.19% | -1.03% | +1.54% | +19.97% |
What strategic announcements or pipeline updates might Dr. Reddy's management be preparing to share with North American institutional investors, particularly given the heavy focus on U.S. cities like Boston, New York, and Princeton?
Could the extensive multi-continent investor roadshow signal an upcoming capital raise, major acquisition, or significant business development deal by Dr. Reddy's Laboratories?
How might Dr. Reddy's increased engagement with Asian institutional investors in Hong Kong and Singapore reflect its strategic ambitions in emerging markets or biosimilar expansion in the Asia-Pacific region?
19
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
